Imunon Inc - Company Profile

Powered by

All the sales intelligence you need on Imunon Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Imunon Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Imunon Inc.

Back to companies

Imunon Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Imunon Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Imunon Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Michael H. Tardugno

Chairman Executive Board Since: 2022 Age: 74

Mr. Michael H. Tardugno has been the Chairman of the company since 2022. Prior to this, he served as the President and Chief Executive Officer of the company from January 2007 to July 2022. Previously, he served as the Senior Vice President and General Manager of Mylan Technologies Inc. Mr. Tardugno also served as the Senior Vice President of Technical Operations at Bristol-Myers Squibb and Senior Vice President of Technology Development and Manufacturing for Bausch & Lomb.

Read Hide full bio of Michael H. Tardugno

Stacy R. Lindborg, Ph.D.

Director; Chief Executive Officer; President Executive Board Since: 2024 Age: 55

Ms. Stacy R. Lindborg has been the Chief Executive Officer, President, and Director of the company since 2024. Prior to this, she served as the Executive Vice President and Co-Chief Executive Officer at BrainStorm Cell Therapeutics. Previously, she served as the Vice President and Head of Global Analytics and Data Sciences at Biogen. Earlier in her career, she worked at Eli Lilly and Company, where she held positions of increasing responsibility, including Head of R&D Strategy.

Read Hide full bio of Stacy R. Lindborg, Ph.D.

Douglas V. Faller, Ph.D

Chief Medical Officer Senior Management Since: 2025 Age: 72

Dr. Douglas V. Faller has been the Chief Medical Officer of the company since 2025. Prior to this, he served as the Chief Medical Officer of Oryzon Genomics. Previously, he served as the Executive Medical Director at Takeda Pharmaceuticals. Dr. Faller also served as the Chief Medical Officer at Skyhawk Therapeutics.

Read Hide full bio of Douglas V. Faller, Ph.D

Khursheed Anwer Ph.D.

Executive Vice President; Chief Science Officer Senior Management Since: 2014 Age: 65

Dr. Khursheed Anwer has been the Executive Vice President and Chief Science Officer of the company since 2014. Prior to this, he served as the Vice President of Research and Development for the Clinical and R&D functions at EGEN. Previously, he served as the Director of Pre-Clinical Development at Valentis Inc. He also held a position at GeneMedicine Inc. from 1993 to 1999.

Read Hide full bio of Khursheed Anwer Ph.D.

Susan Eylward

General Counsel; Secretary Senior Management Since: 2024 Age: 45
Gain a 360-degree view of Imunon Inc and make more informed decisions for your business Gain a 360-degree view of Imunon Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer